Outputs (22)

Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results (2014)
Journal Article
BYRNE, J., Jackson, G. H., Morgan, G. J., Davies, F. E., Wu, P., Gregory, W. M., Bell, S. E., Szubert, A. J., Navarro Coy, N., Drayson, M. T., Owen, R. G., Feyler, S., Ashcroft, A. J., Ross, F. M., Roddie, H., Rudin, C., Boyd, K. D., Osborne, W. L., Cook, G., & Anthony Child, J. (2014). Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results. British Journal of Haematology, 166(1), https://doi.org/10.1111/bjh.12861

The Predictive Value of Circulating Anti-Müllerian Hormone in Women With Polycystic Ovarian Syndrome Receiving Clomiphene Citrate: A Prospective Observational Study (2013)
Journal Article
Mahran, A., Abdelmeged, A., El-Adawy, A. R., Eissa, M. K., Shaw, R. W., & Amer, S. A. (2013). The Predictive Value of Circulating Anti-Müllerian Hormone in Women With Polycystic Ovarian Syndrome Receiving Clomiphene Citrate: A Prospective Observational Study. Journal of Clinical Endocrinology and Metabolism, 98(10), 4170-4175. https://doi.org/10.1210/jc.2013-2193

CONTEXT:
Elevated serum anti-Müllerian hormone (AMH) concentration in women with polycystic ovarian syndrome (PCOS) is known to lower sensitivity of ovarian follicles to circulating FSH. This effect may compromise the outcome of clomiphene citrate (... Read More about The Predictive Value of Circulating Anti-Müllerian Hormone in Women With Polycystic Ovarian Syndrome Receiving Clomiphene Citrate: A Prospective Observational Study.